In conclusion, our data confirm the value of multiple AutoAbs testing for three particular antigens in preclinical RA, while suggesting that others may also have value (anti-collagen-II AutoAbs notably) and allowing for the exclusion of some (ANA, RF-IgG, anti-Collagen-I but not II). This evidence concerns the gene BTG3 and rheumatoid arthritis.